In our study, among the 25 NSCLC patients with any grade of AST/ALT elevation, seven were HBV patients (7/32 patients, 21.8%) and 18 were non‐HBV patients (18/205 patients, 8.8%). Here, GPT is linked to non-small cell lung carcinoma.